| 
        
          |  | 
 WOMEN'S HEALTH: ESTROGEN, PROGESTINS AND BLOOD PRESSURE.R.M.Korth. 
            Research in General Medicine Fida, Munich, Germany.
 
 Aim: A hypertensive risk was invented 
            here with women during pregnancy, intolerance to glucose (IGTT:www.fidabus.com) 
            or with hormone users or with non-pregnant women at metabolic risk 
            beyond hormone use (out of 231).
 
 Methods: Initial biomarkers were 
            anonymously enrolled and oral glucose tolerance was tested (1h-50g-oGTT 
            Reflotron Roche, R.M.Korth, jmhg 3, 279-289, 2006).
 
 Results: First, pregnant women 
            with reversible IGTT had values between 140-169 mg/dl glucose (16% 
            out of 180, aged 31±5 years) having initially normal weight (23±4 
            kg/m²) reporting healthy food and lifestyle. Normal blood pressure 
            was observed (week 22±2: 104±13/64±11 mmHg; week 38±2: 110±8/73±5 
            mmHg, ±1S.D.). Pregnant women with persisting control-IGTT tended 
            to gestation diabetes elsewhere (4% ≥170 mg/dl, 1-h-100g glucose). 
            Second, oral contraceptives were not correlated with raised blood 
            pressure (p>0.1) probably as weight and lipids were normal (49 
            out of 231, 22±4 kg/m², aged 27±7 years, 117±13/82±9 mmHg, LDL: 127±36, 
            HDL: 66±14 mg/dl). Third, aging women with menopausal HRT-hormones 
            (15 out of 46, aged 51±9 years, 25±5 kg/m²) were compared to those 
            without HRT and led away from raised blood pressure (p>0.35). Overall, 
            non-pregnant women with IGTT and mixed hyperlipidemia showed hypertension 
            (14 out of 231 (6%), aged 32±10 years, 26±6 kg/m², LDL: 167±65, HDL: 
            54±9,Trig:254±73 mg/dl, 136±25/97±12 mmHg). Indeed, women with IGTT 
            or mixed hyperlipidemia had significantly higher blood pressure than 
            appropriate controls (p<0.003) and multivariate analysis provided 
            evidence for direct risk of diastolic hypertension (p<0.05).
 
 Conclusion: This model is suitable 
            to adress hormonal compositions without hypertension as only participants 
            with IGTT-hyperinsulinemia and/or mixed hyperlipidemia were at direct 
            risk for diastolic hypertension.
 
 Accepted Abstract at the 78th European Atherosclerosis Society Congress 
            (A226-0001-00316, EAS 2010 in Hamburg, Germany).
 
 
 |  |  |